Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
688136 Kexing Biopharm
- 38.52
- +0.72+1.90%
Market Closed Apr 24 15:00 CST
7.69BMarket Cap243.80P/E (TTM)
38.86High36.94Low60.54KlotVolume37.58Open37.80Pre Close228.69MTurnover3.03%Turnover Ratio243.80P/E (Static)199.64MShares42.1052wk High4.70P/B7.69BFloat Cap13.6752wk Low45.36Limit Up199.64MShs Float55.48Historical High30.24Limit Down5.08%Amplitude10.61Historical Low--Dividend TTM37.78Avg Price26.47KlotAsk--Div YieldTTM100Lot Size28.47KlotBid
Kexing Biopharm Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -2.50%554.56M | -7.46%305.96M | -18.79%439.76M | -26.86%353.79M | -27.58%568.8M | -47.56%330.63M | -13.90%541.52M | -45.58%483.68M | -10.51%785.38M | -4.82%630.46M |
| Transactional financial assets | ---- | -42.46%162.25M | -56.05%74.09M | -27.56%188.5M | ---- | 76.07%281.97M | -26.77%168.57M | 767.44%260.23M | ---- | -30.40%160.15M |
| Notes receivable and accounts receivable | 75.19%500.56M | 17.53%428.55M | 18.96%437.43M | -2.01%353.75M | -20.84%285.72M | 2.97%364.63M | 1.89%367.7M | 7.06%361.01M | -3.14%360.93M | 9.90%354.12M |
| -Notes receivable | 125.86%25.29M | -40.70%22.52M | -51.36%20.79M | -52.08%11.82M | -52.49%11.2M | 36.75%37.97M | 59.79%42.75M | -24.36%24.66M | -35.22%23.57M | 32.69%27.77M |
| -Accounts receivable | 73.13%475.28M | 24.30%406.03M | 28.22%416.64M | 1.66%341.93M | -18.63%274.52M | 0.09%326.65M | -2.75%324.95M | 10.43%336.35M | 0.34%337.37M | 8.31%326.35M |
| Other receivables (including interest and dividends) | 257.34%15.9M | 251.59%16.12M | 31.21%5.64M | 28.75%4.79M | 36.97%4.45M | 31.51%4.58M | 56.48%4.3M | 20.71%3.72M | 14.27%3.25M | -46.71%3.49M |
| -Other receivable | 257.34%15.9M | ---- | 31.21%5.64M | ---- | 36.97%4.45M | ---- | 56.48%4.3M | ---- | 14.27%3.25M | ---- |
| Advance payment | -73.08%6.71M | -32.37%13.42M | 7.19%18.04M | 25.11%32.58M | 16.70%24.93M | 110.13%19.84M | 33.69%16.83M | 151.28%26.04M | 101.89%21.36M | 37.65%9.44M |
| Inventories | -25.90%141.81M | -16.82%141.62M | -11.10%155.87M | -12.48%178.31M | -8.08%191.36M | -15.55%170.27M | -7.24%175.33M | 4.08%203.73M | 20.93%208.18M | 18.55%201.61M |
| Receivable financing | 12.30%63.25M | 13.76%50.92M | 110.09%78.71M | 137.55%47.15M | 144.20%56.32M | 475.47%44.76M | 2,440.28%37.46M | 760.19%19.85M | 130.62%23.06M | -72.31%7.78M |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | -65.77%1.23M | --2.14M | --3.04M | --3.44M | --3.59M |
| Other current assets | 144.78%5.01M | 121.44%4.26M | -39.07%1.97M | -81.52%1.89M | -64.09%2.05M | -20.00%1.92M | 59.05%3.23M | -30.30%10.2M | -61.99%5.7M | -61.27%2.4M |
| Total current assets | 13.60%1.29B | -7.93%1.12B | -8.02%1.21B | -15.37%1.16B | -19.68%1.13B | -11.16%1.22B | -7.76%1.32B | -7.46%1.37B | -3.39%1.41B | -4.15%1.37B |
| Non Current assets | ||||||||||
| Other equity investment | 5.73%15.86M | 0.00%15M | 0.00%15M | 0.00%15M | 0.00%15M | --15M | --15M | --15M | --15M | ---- |
| Other non-current financial assets | -18.86%183.61M | -14.72%212.36M | -19.27%212.36M | -6.53%226.3M | -6.53%226.3M | 2.24%249.02M | 7.99%263.03M | -2.16%242.11M | -2.16%242.11M | 21.78%243.56M |
| Investment real estate | -6.05%20.61M | -6.11%20.9M | -5.79%21.28M | -5.79%21.59M | -5.63%21.93M | -5.55%22.26M | 252.80%22.59M | --22.91M | --23.24M | --23.57M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --308.68K | --1.29M |
| Fixed assets | 21.15%974.87M | ---- | 31.47%1.01B | ---- | 6.08%804.69M | ---- | 46.33%768.75M | ---- | 67.84%758.54M | ---- |
| Constru in process | -52.54%176.82M | ---- | -54.95%169.44M | ---- | 45.21%372.56M | ---- | -13.12%376.16M | ---- | -40.13%256.57M | ---- |
| Intangible assets | 41.84%225.14M | 13.47%183.76M | -3.62%156.64M | -4.08%155.16M | -4.28%158.72M | -8.77%161.95M | -9.24%162.52M | 375.72%161.76M | 515.03%165.82M | 560.83%177.52M |
| Development expenditure | --30.88M | -81.42%21.94M | -89.76%7.21M | ---- | ---- | --118.07M | --70.41M | ---- | ---- | ---- |
| Long deferred expense | 533.19%19.49M | 249.84%20.65M | 155.59%22.17M | -87.03%1.44M | -77.98%3.08M | -60.20%5.9M | -49.24%8.67M | -42.54%11.11M | -35.94%13.98M | -40.94%14.83M |
| Deferred tax assets | -12.51%117.22M | 27.23%112.32M | 26.10%116.4M | 92.29%131.43M | 100.40%133.98M | 120.96%88.28M | 301.27%92.31M | 526.84%68.35M | 452.43%66.85M | 1,092.85%39.95M |
| Usufruct assets | 13.65%25.58M | 2.08%28.76M | 0.96%31.94M | 4.25%35.12M | -39.83%22.51M | -31.51%28.18M | -35.61%31.64M | -34.67%33.69M | -32.91%37.41M | -31.41%41.14M |
| Other non current assets | -40.29%80.42M | -17.12%91.16M | 17.36%120.19M | -26.32%126.1M | -22.40%134.68M | -41.26%109.99M | -34.46%102.41M | -6.21%171.16M | 40.38%173.57M | 47.21%187.25M |
| Total non current assets | -1.21%1.87B | -4.09%1.88B | -1.37%1.89B | 8.99%1.9B | 8.22%1.9B | 13.52%1.96B | 17.19%1.91B | 19.67%1.75B | 28.15%1.75B | 46.96%1.72B |
| Total assets | 4.33%3.16B | -5.56%3B | -4.08%3.1B | -1.73%3.06B | -4.22%3.03B | 2.58%3.18B | 5.55%3.23B | 6.00%3.12B | 11.87%3.16B | 18.86%3.1B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 122.96%269.12M | 53.01%220.37M | -20.26%133.98M | -4.39%120.84M | -25.81%120.7M | -55.10%144.02M | -62.73%168.02M | -67.09%126.39M | -41.11%162.69M | 30.48%320.78M |
| Notes payable and accounts payable | 5.56%204.23M | -22.10%155.95M | 6.28%182.4M | 22.85%171.98M | -10.93%193.46M | -9.14%200.18M | -15.12%171.62M | -18.92%139.99M | -3.56%217.2M | 19.26%220.31M |
| -Accounts payable | 5.56%204.23M | -22.10%155.95M | 6.28%182.4M | 22.85%171.98M | -10.93%193.46M | -9.14%200.18M | -15.12%171.62M | -18.92%139.99M | -3.56%217.2M | 19.26%220.31M |
| Contract liabilities | -53.24%9.18M | 12.38%6.22M | -46.33%4.87M | 31.89%6.98M | 12.97%19.64M | 6.97%5.53M | 270.74%9.07M | 12.22%5.29M | 142.82%17.38M | -4.53%5.17M |
| Advance receipts | -25.45%596.23K | -11.11%515K | -0.91%1.12M | 838.57%521.43K | 31.26%799.74K | --579.37K | --1.13M | --55.56K | --609.26K | ---- |
| Salaries payable | 20.01%29.52M | 0.54%13.71M | -17.86%13.53M | -2.67%22.98M | -19.56%24.6M | -10.02%13.64M | 6.47%16.47M | 8.46%23.61M | -10.52%30.58M | 9.13%15.16M |
| Taxs payable | 70.67%7.09M | -55.79%4.49M | -1.81%8.59M | 32.84%4.65M | -58.58%4.16M | -13.25%10.16M | -12.86%8.75M | -36.89%3.5M | 64.47%10.03M | 131.06%11.71M |
| Other payable (including interest and dividends) | 30.67%27.5M | 47.21%26.82M | 38.52%27.13M | -3.02%20.32M | 1.56%21.05M | -5.57%18.22M | -7.58%19.59M | 14.53%20.95M | 19.08%20.72M | 4.98%19.29M |
| -Interest payable | ---- | ---- | --170.72K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | 30.67%27.5M | ---- | 37.65%26.96M | ---- | 1.56%21.05M | ---- | -7.58%19.59M | ---- | 19.08%20.72M | ---- |
| Non current liabilities due within one year | 15.61%325.7M | 6.66%327.2M | 226.69%414.63M | 230.89%417.15M | 293.18%281.73M | 411.57%306.76M | 171.08%126.92M | 577.91%126.07M | 289.73%71.66M | 229.88%59.96M |
| Other current liabilities | 248.77%13.45M | 39.53%7.66M | -83.96%1.46M | -68.35%1.22M | -54.56%3.86M | -64.97%5.49M | 25.97%9.1M | -73.60%3.85M | -55.08%8.49M | 71.07%15.67M |
| Total current liabilities | 32.30%886.4M | 8.28%762.94M | 48.44%787.71M | 70.48%766.64M | 24.22%669.99M | 5.47%704.58M | -29.82%530.66M | -29.76%449.7M | -10.64%539.37M | 33.43%668.05M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -34.17%7.48M | -35.19%10.1M | -35.23%10.56M | 55.40%13.26M | -21.93%11.36M | 138.62%15.59M | 149.49%16.3M | 19.85%8.53M | 104.34%14.55M | --6.53M |
| Long term deferred income | -40.79%3.15M | 46.67%3.01M | 71.95%3.69M | 124.91%5.06M | 610.27%5.32M | 136.70%2.05M | 135.93%2.14M | 136.33%2.25M | -24.57%749.26K | -43.57%866.47K |
| Lease liabilities | -16.87%14.78M | -11.21%18M | -0.41%20.96M | 1.65%21.55M | -28.75%17.79M | -32.42%20.27M | -39.83%21.05M | -44.97%21.2M | -42.29%24.96M | -37.41%30M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --178.33K |
| Total non current liabilities | -12.83%636.59M | -12.50%616.9M | -24.56%698.53M | -22.57%673.36M | -10.88%730.3M | 19.29%705.04M | 125.88%925.96M | 140.71%869.6M | 160.37%819.49M | 174.35%591.01M |
| Total liabilities | 8.76%1.52B | -2.11%1.38B | 2.03%1.49B | 9.15%1.44B | 3.05%1.4B | 11.96%1.41B | 24.92%1.46B | 31.74%1.32B | 47.97%1.36B | 75.83%1.26B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.22%199.64M | 0.00%199.2M | 0.00%199.2M | 0.25%199.2M | 0.25%199.2M | 0.25%199.2M | 0.25%199.2M | 0.00%198.7M | 0.00%198.7M | 0.00%198.7M |
| Capital reserve funds | 0.54%1.29B | 0.27%1.28B | 0.12%1.28B | 0.49%1.28B | 0.58%1.28B | 0.73%1.28B | 0.91%1.28B | 0.81%1.28B | 0.62%1.27B | 0.41%1.27B |
| Surplus reserve funds | 25.71%24.96M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 0.00%19.85M | 53.19%19.85M |
| Retained profit | 21.03%151.83M | -45.44%142.63M | -48.79%137.33M | -55.09%137.85M | -60.27%125.45M | -25.16%261.43M | -34.42%268.18M | -32.54%306.98M | -25.87%315.74M | -15.14%349.32M |
| Less:Treasury stock | --31.12M | --31.12M | --31.12M | --20M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other composite income | 17,887.10%1.11M | --351.27K | --339.12K | --380.54K | ---6.26K | ---- | ---- | ---- | ---- | ---- |
| Shareholders equity without minority interests | 0.55%1.63B | -8.30%1.62B | -9.06%1.61B | -10.10%1.62B | -10.08%1.63B | -4.25%1.76B | -6.79%1.77B | -7.10%1.8B | -5.36%1.81B | -2.66%1.84B |
| Minority interests | -9.14%4.34M | -13.25%5.34M | -16.49%6.35M | 206.55%3.86M | 288.82%4.77M | 594.46%6.16M | 1,997.45%7.61M | ---3.62M | ---2.53M | ---1.25M |
| Total shareholder equity | 0.52%1.64B | -8.32%1.62B | -9.10%1.61B | -9.70%1.62B | -9.69%1.63B | -3.85%1.77B | -6.37%1.77B | -7.29%1.8B | -5.49%1.81B | -2.72%1.84B |
| Total liabilityies and equity | 4.33%3.16B | -5.56%3B | -4.08%3.1B | -1.73%3.06B | -4.22%3.03B | 2.58%3.18B | 5.55%3.23B | 6.00%3.12B | 11.87%3.16B | 18.86%3.1B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | -- | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs